Why Integration?
It is the composite profile of a molecule, rather than any specific attribute, that dictates its success as a drug. Models that accommodate deficiencies in one characteristic but are compensated for in another will improve significantly the advancement of better development candidates.
ADMETRx has developed a multicriteria decision-making tool to facilitate better use of data. The model considers both context dependence and interrelationships of the properties. Recognizing the importance of the highest quality data to make the advancement decision, we provide ADME profiling services to support the model, although a client’s own data may also be used.
ADMETRx is committed to providing solutions to our industry’s discovery challenges. Our objective is to team with our clients in identifying the winners earlier and advance only those into clinical development. This will ultimately lead to improved drug approvals and decreased overall cost.